Sanofi-Aventis SA denied that it offered Genzyme Corp. a price range in a Sept. 20 meeting between the chief executives of the companies.
“We offered no price range,” Jean-Marc Podvin, a spokesman for Paris-based Sanofi, said in a statement read by telephone today.
